Interestingly, considering the cut-off values of 5% and 10% positive tumour cells, we found the co-expression of EGFR/HER-4 to be significantly associated with disease-free survival in patients with Dukes’ C and D colon cancer in this study (Table 5). This evidence concerns the gene ERBB4 and malignant colon neoplasm.